会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMPOSITIONS AND METHODS FOR REGULATING SAS1R
    • 用于调节SAS1R的组合物和方法
    • US20120252031A1
    • 2012-10-04
    • US13479167
    • 2012-05-23
    • John C. HerrMonika SachdevArabinda Mandal
    • John C. HerrMonika SachdevArabinda Mandal
    • C12Q1/37G01N33/573
    • C07K16/28A61K38/1709A61K38/177A61K38/4886A61K39/0006C07K2317/76G01N2333/96486G01N2500/04
    • The present invention provides compositions and methods useful for regulating fertilization and for use as a contraceptive based on the discovery herein of an oocyte specific protein, SAS1R (Sperm Acrosomal SLLP1 Receptor), which is a sperm protein receptor. Six SAS1R variants, including the full length SAS1R, were identified. mSLLP1 and SAS1R co-localized to oocytes and to acrosomes of acrosome-reacted sperm. Interactions between mSLLP1 and SAS1R were demonstrated by far-western analysis, in a yeast two-hybrid system under stringent selection conditions, and by immunoprecipitation of SAS1R by anti-mSLLP1 as well as the converse. Purified recombinant SAS1R was found to have protease activity, to inhibit fertilization in-vitro, and to induce an immune response in females. Together, the results suggest SAS1R is a proteolytically active, oocyte and early embryo specific oolemmal metalloprotease receptor for the sperm intra-acrosomal ligand SLLP1 and is a target for regulating fertilization and as a contraceptive.
    • 本发明提供了用于调节受精和用作基于本发明的卵母细胞特异性蛋白质SAS1R(精子顶体SLLP1受体)的组合物和方法,其是精子蛋白受体。 确定了六种SAS1R变体,包括全长SAS1R。 mSLLP1和SAS1R共同定位于卵母细胞和顶体反应精子的顶体。 通过远西分析,在严格选择条件下的酵母双杂交系统中,通过抗mSLLP1和相反的免疫沉淀法证明了mSLLP1和SAS1R之间的相互作用。 发现纯化的重组SAS1R具有蛋白酶活性,在体外抑制受精,并在雌性中诱导免疫应答。 结果表明,SAS1R是精子顶体内配体SLLP1的蛋白水解活性,卵母细胞和早期胚胎特异性卵母细胞金属蛋白酶受体,是调节受精和避孕的目标。
    • 3. 发明申请
    • COMPOSITIONS AND METHODS FOR REGULATING SAS1R
    • 用于调节SAS1R的组合物和方法
    • US20100183617A1
    • 2010-07-22
    • US12613947
    • 2009-11-06
    • John C. HerrMonika SachdevArabinda Mandal
    • John C. HerrMonika SachdevArabinda Mandal
    • A61K39/395G01N33/567C07K16/18A61K39/00A61K38/46
    • C07K16/28A61K38/1709A61K38/177A61K38/4886A61K39/0006C07K2317/76G01N2333/96486G01N2500/04
    • The present invention provides compositions and methods useful for regulating fertilization and for use as a contraceptive based on the discovery herein of an oocyte specific protein, SAS1R (Sperm Acrosomal SLLP1 Receptor), which is a sperm protein receptor. Six SAS1R variants, including the full length SAS1R, were identified. mSLLP1 and SAS1R co-localized to oocytes and to acrosomes of acrosome-reacted sperm. Interactions between mSLLP1 and SAS1R were demonstrated by far-western analysis, in a yeast two-hybrid system under stringent selection conditions, and by immunoprecipitation of SAS1R by anti-mSLLP1 as well as the converse. Purified recombinant SAS1R was found to have protease activity, to inhibit fertilization in-vitro, and to induce an immune response in females. Together, the results suggest SAS1R is a proteolytically active, oocyte and early embryo specific oolemmal metalloprotease receptor for the sperm intra-acrosomal ligand SLLP1 and is a target for regulating fertilization and as a contraceptive.
    • 本发明提供了用于调节受精和用作基于本发明的卵母细胞特异性蛋白质SAS1R(精子顶体SLLP1受体)的组合物和方法,其是精子蛋白受体。 确定了六种SAS1R变体,包括全长SAS1R。 mSLLP1和SAS1R共同定位于卵母细胞和顶体反应精子的顶体。 通过远西分析,在严格选择条件下的酵母双杂交系统中,通过抗mSLLP1和相反的免疫沉淀法证明了mSLLP1和SAS1R之间的相互作用。 发现纯化的重组SAS1R具有蛋白酶活性,在体外抑制受精,并在雌性中诱导免疫应答。 结果表明,SAS1R是精子顶体内配体SLLP1的蛋白水解活性,卵母细胞和早期胚胎特异性卵母细胞金属蛋白酶受体,是调节受精和避孕的目标。